Physical Exercise Cardiovascular Adaptation Monitoring in Pregnancy (PE-CAMP Study) (PE-CAMP)

Physical Exercise, Cardiovascular Adaptation Monitoring in Pregnancy

The main theme of this study focuses on providing evidence of the impact of antenatal physical activity on maternal/foetal cardiovascular changes during pregnancy and maternal cardiovascular adaptations during the early postpartum period.

Study Overview

• Status: Completed
• Conditions: Pregnancy Related; Pregnant Women; Maternal-Fetal Relations
• Intervention / Treatment: Behavioral: Exercise group

Detailed Description

Overwhelming research supports the general benefit of antenatal physical activity (APA) for pregnant women, but there is a lack of knowledge about the influence of exercise on cardiovascular physiology in healthy and overweight pregnant women and their foetuses. Also some research supports the theory of foetal programming; which establish that maternal habits during pregnancy will impact in-utero environment, so if this maternal habits are healthy ones they could improve foetal health.

Cardio vascular disease (CVD) was the top cause of death all over the world in 2015. In Wales CVD as cause of death is still one of the top ones. However, these statistics could be improved if people adopt healthier lifestyle habits, since 54% and 45% of Welsh women are overweight/obese or sedentary respectively. Pregnancy seems to be a teachable moment for women and the starting point of adopting healthy life-style habits. Therefore, by introducing Welsh pregnant women to exercise, there is the potential to improve their health and of their foetuses an also exert an exponential impact on future generations.

The main theme of this study focuses on providing evidence of the impact of APA on maternal/foetal cardiovascular changes during pregnancy and maternal cardiovascular adaptations during the early postpartum period.

This is a 3-year study carried out in Swansea University, Singleton Hospital.

The project leading to this application has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 663830.

Healthy pregnant women with no contraindications for exercise will be eligible for the study and those who want to participate in the project will be allocated into an exercise group (EG) or a control group (CG). EG participants will receive an intervention based on an APA during 20-24weeks, CG participants will follow their standard health care during pregnancy.

All participants must attend three cardiovascular assessment protocols (18-22 weeks & 32-36weeks during pregnancy, 12weeks postpartum). These protocols will involve maternal/foetal electrocardiograph and echocardiograph evaluation, heart-rate monitoring and moderate physical exercise (walking).

• Study Type: Interventional
• Enrollment (Actual): 138
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • Swansea, United Kingdom, SA2 8QA
    • Singleton Hospital, Maternity Unit

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 40 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

1. Women with healthy pregnancy
2. Aged 18-40 years
3. Single pregnancy
4. Pregnancy stage <= 16 weeks' gestation at the point of consent.
5. Two or fewer previous term pregnancies (as physiology can be altered by multiple pregnancies).

Exclusion Criteria:

1. Known complications of pregnancy
2. Known contraindications for physical exercise
3. Known major cardiovascular or respiratory pathology
4. Three or more previous term pregnancies
5. Inability to communicate in English or Welsh.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Basic Science
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Exercise group; An antenatal physical activity (APA) programme will be designed for participants in the exercise group.	Behavioral: Exercise group; An antenatal physical activity (APA) programme will be designed for participants in the exercise group. The APA will last for 20-24 weeks. Participants in the EG must enrol in the APA between their 12-16 weeks of gestation. The APA programme has a frequency of three times a week, which involves aerobic, strength and stretching exercises. The intensity of the APA programme is individually calculated for each participant based on their pre-pregnancy fitness level. Single sessions of the APA programme last 50-60min.
No Intervention: Control Group; Sedentary participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in maternal cardiac output during and after pregnancy.	Maternal cardiac output at rest, during exercise and after exercise measured in L/min would be recorded from study participants to analyse and compare potential changes inter and intra group.	18 and 36 weeks of gestation, 12 weeks postpartum.
Changes in maternal heart rate during and after pregnancy.	Maternal heart rate at rest and after exercise would be recorded in beats per minute to be analysed and compared inter and intra group.	18 and 36 weeks of gestation, 12 weeks postpartum.
Changes in maternal heart rate variability during and after pregnancy	Maternal heart rate variability at rest, during and after exercise would be measured by r to r interval. It would be recorded and analysed to compare inter and intra group changes.	18 and 36 weeks of gestation, 12 weeks postpartum.
Foetal heart rate	Foetal heart rate baseline would be measured at rest, during and after exercise. It would be analysed and compared in between groups.	36 weeks pregnancy

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in active pregnant women energy expenditure	Data obtained from accelerometer devices worn by exercise group participants.	18 and 36 weeks pregnancy.
Changes in sedentary pregnant women energy expenditure	Data obtained from accelerometer devices worn by control group participants.	18 and 36 weeks pregnancy.
Energy expenditure during the early postpartum period.	Data obtained from accelerometer devices worn by all participants in the study.	12 weeks postpartum.
Gestational weight gain.	Weight gain during pregnancy measured in kilograms would be recorded to be compared in between study groups.	36 weeks pregnancy.
Changes in maternal body fat percentage during pregnancy.	Body fat percentage calculated from skinfold-thickness measures would be compared in between study groups.	18 and 36 weeks pregnancy.
Birth weight	Birth weight from new borns recorded in kilograms would be collected from maternal records. It would be analysed and compared between groups.	Second week after birth.
Results from Qol-Grav questionnaire during second and third trimester of pregnancy.	The Qol-Grav questionnaire is a validated questionnaire used to measure quality of life in pregnant women. This questionnaire would be filled in by study participants and analysed to record their quality of life during the current pregnancy. Scores derived from the questionnaire would be analysed and compared between groups. The following total score scale is presented: 9-18: Excellent quality of life. 19-27: Very good quality of life. 28-36: Good quality of life. 37-45: Not very good quality of life.	18 and 36 weeks pregnancy.
Pre-pregnancy physical activity levels recorded by the modified physical activity questionnaire.	Participants' pre-pregnancy physical activity levels would be registered using the modified physical activity questionnaire. This questionnaire records information about activities performed for the three months before pregnancy. Intensity of the activity would be recorded using three different levels of intensity (low, moderate and vigorous). Average time spent in each activity would be recorded in minutes. These values would be used to measure time and intensity spent in physical activity before pregnancy, and would be compared between groups.	12 weeks pregnancy.
Pregnancy physical activity levels during first trimester recorded by the modified physical activity questionnaire.	Participants' physical activity levels during the first trimester of pregnancy would be registered using the modified physical activity questionnaire. This questionnaire records information about activities performed during the first three months of pregnancy. Intensity of the activity would be recorded using three different levels of intensity (low, moderate and vigorous). Average time spent in each activity would be recorded in minutes. These values would be used to measure time and intensity spent in physical activity during pregnancy, and would be compared between groups.	12 weeks pregnancy.
Pregnancy physical activity levels during second and third trimester recorded by the modified physical activity questionnaire.	Participants' physical activity levels during the second and third trimester of pregnancy would be registered using the modified physical activity questionnaire. This questionnaire records information about activities performed during the second an third trimesters of pregnancy. Intensity of the activity would be recorded using three different levels of intensity (low, moderate and vigorous). Average time spent in each activity would be recorded in minutes. These values would be used to measure time and intensity spent in physical activity during pregnancy, and would be compared between groups.	36 weeks pregnancy.
Changes in quality of sleep during pregnancy.	Two questionnaires would be used to measure participants' quality of sleep during their pregnancy. These questionnaires are the Pittsburgh Sleep Quality Index and the Insomnia Severity Index.	18 and 36 weeks of pregnancy.
Quality of sleep during postpartum.	Two questionnaires would be used to measure participants' quality of sleep during the postpartum period. These questionnaires are the Pittsburgh Sleep Quality Index and the Insomnia Severity Index.	12 weeks postpartum.
Sleep patterns in the three months old infant	The Brief Screening Questionnaire for Infant Sleep Problems would be used to register sleep patterns in the three months old infants born from study participants. Items recorded in the questionnaire are the following: sleep arrangement, time spent sleeping during the day and night, number of wakings per night, mode of falling asleep, time spent in wakefulness and normal time of falling asleep at night.	12 weeks postpartum.

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Type of birth.	Type of delivery such as vaginal, cesarean section or instrumental birth would be recorded from maternal records after birth.	2 weeks postpartum.
Type of analgesia used during labour	Type of analgesia (pharmacological or non-pharmacological) used during labour would be recorded from maternal records after birth.	2 weeks postpartum.
New born's Apgar score	Apgar score is a scale that measures health in the new born. This scale focuses on five parameters (skin colour, heart rate, reflexes and responsivness, muscular tone, and breathing rate), each of them rated from 0 to 2. This test is performed at the first and fifth minute of new born's life. Scores above 7 are consider normal, scores below 7 indicates that the new born needs medical attention. Scores from both tests (1min and 5min) would be recorded from maternal records after birth.	2 weeks postpartum.
Changes in maternal hand grip strength during pregnancy.	Maternal hand grip strength would be measured using a hand grip dynamometer. This test would be performed during the second and third trimester of pregnancy.	18 and 36 weeks of pregnancy.
Maternal hand grip strength during postpartum.	Maternal hand grip strength would be measured using a hand grip dynamometer. This test would be performed during the postpartum period.	12 weeks postpartum.
Changes in maternal upper body range of motion during pregnancy.	Maternal upper body flexibility during second and third trimester would be measured using the back scratch test. This test measures how close the hands can be brought together behind the back.	18 and 36 weeks of pregnancy.
Maternal upper body range of motion during postpartum.	Maternal upper body flexibility during the early postpartum would be measured using the back scratch test. This test measures how close the hands can be brought together behind the back.	12 weeks postpartum.

Collaborators and Investigators

• Sponsor: Swansea University
• Collaborators: European Union
• Investigators: Study Chair: MICHAEL J LEWIS, Prof, Swansea University

Publications and helpful links

General Publications

• Carpenter RE, D'Silva LA, Emery SJ, Uzun O, Rassi D, Lewis MJ. Changes in heart rate variability and QT variability during the first trimester of pregnancy. Physiol Meas. 2015 Mar;36(3):531-45. doi: 10.1088/0967-3334/36/3/531. Epub 2015 Feb 18.
• Carpenter RE, Emery SJ, Uzun O, Rassi D, Lewis MJ. Influence of physical exercise on baroreceptor sensitivity during pregnancy. J Matern Fetal Neonatal Med. 2017 Mar;30(5):514-519. doi: 10.1080/14767058.2016.1179275. Epub 2016 May 12.

Study record dates

Study Major Dates

• Study Start (Actual): April 26, 2018
• Primary Completion (Actual): November 30, 2021
• Study Completion (Actual): December 31, 2021

Study Registration Dates

• First Submitted: November 13, 2018
• First Submitted That Met QC Criteria: November 18, 2018
• First Posted (Actual): November 21, 2018

Study Record Updates

• Last Update Posted (Actual): October 26, 2022
• Last Update Submitted That Met QC Criteria: October 25, 2022
• Last Verified: October 1, 2022

More Information

Terms related to this study

• Keywords: Cardiovascular system; Antenatal physical activity; Maternal heart rate; Foetal heart rate
• Other Study ID Numbers: 663830-SU-079; 17/WA/0414 (Other Identifier: REC Reference)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No